Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
The molecular mechanisms underlying metastasis in pheochromocytoma/paraganglioma (mPPGL) remain to be explored. Here, the authors perform genomic and immunogenomic profiling of mPPGL tumors and suggest potential biomarkers for risk of metastasis and immunotherapy response.
Similar Items
-
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
by: María Monteagudo, et al.
Published: (2021-09-01) -
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
by: Sara Mellid, et al.
Published: (2023-07-01) -
Novel <i>DNMT3A</i> Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma
by: Sara Mellid, et al.
Published: (2020-11-01) -
A Novel Approach for the Identification of Pharmacogenetic Variants in <i>MT-RNR1</i> through Next-Generation Sequencing Off-Target Data
by: Javier Lanillos, et al.
Published: (2020-07-01) -
High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
by: Lorena Maestre, et al.
Published: (2020-01-01)